ROIV
Roivant Sciences Ltd. Common Shares
stockNASDAQ
roivant is a global healthcare company focused on rapidly developing innovative medicines. we believe that the key to unlocking innovation in drug discovery and drug commercialization is to reduce the time and cost of the drug development process. we solve this problem by building vants – nimble, entrepreneurial biotech companies with a unique approach to sourcing talent, aligning economic incentives, and deploying technology to drive greater efficiency in pharma r&d; and commercialization. the goal of our model is to ensure that important medicines rapidly reach patients who suffer from serious diseases. we focus on disease areas where the magnitude of r&d; investment from industry is disproportionately low relative to societal medical needs. we also launch new vants to directly improve the process of developing and commercializing new medicines. our pipeline spans multiple therapeutic areas through partnerships with academic institutions and biopharmaceutical companies, including tak
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 37.45 | 2026-10-22 | +0.76% | 2.208 |
| 1M | 36.50 | 2026-09-29 | +3.38% | 1.109 |
| 3M | 32.87 | 2026-07-29 | +14.80% | 0.485 |
| 6M | 27.52 | 2026-04-29 | +37.12% | 0.816 |
| 1Y | 18.76 | 2025-10-29 | +101.14% | 1.021 |
| 2Y | 11.58 | 2024-10-29 | +225.86% | — |
| 5Y | 7.94 | 2021-10-29 | +375.24% | 0.935 |
Roivant Sciences Ltd. Common Shares (NASDAQ:ROIV) stock price today is $37.73, and today's volume is 637,089. ROIV is up 1.682% today. The 30 day average volume is 7.52M. ROIV market cap is $27.26B with 722.32M shares outstanding.